Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Pancreatic Cancer for Phase II”

470 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 470 results

Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT01838317
What this trial is testing

A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas

Who this might be right for
Cancer of the Pancreas
University of Texas Southwestern Medical Center 14
Large-scale testing (Phase 3)Study completedNCT02172976
What this trial is testing

Randomized Multicenter Phase II/III Study With Adjuvant Gemcitabine Versus Neoadjuvant / Adjuvant FOLFIRINOX for Resectable Pancreas Carcinoma

Who this might be right for
Resectable Prancreas Carcinoma
Krankenhaus Nordwest 40
Testing effectiveness (Phase 2)Ended earlyNCT04390243
What this trial is testing

Binimetinib and Encorafenib for the Treatment of Pancreatic Cancer in Patients With a Somatic BRAF V600E Mutation

Who this might be right for
Locally Advanced Pancreatic CarcinomaMetastatic Pancreatic CarcinomaRecurrent Pancreatic Carcinoma+2 more
Academic and Community Cancer Research United 6
Testing effectiveness (Phase 2)Study completedNCT00587964
What this trial is testing

Phase II Trial of Stereotactic Radiosurgery Boost Following Surgical Resection for Brain Metastases

Who this might be right for
Brain MetastasisBladder CancerBreast Cancer+10 more
Memorial Sloan Kettering Cancer Center 51
Testing effectiveness (Phase 2)Study completedNCT00095966
What this trial is testing

Sorafenib and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage II Pancreatic Cancer+2 more
National Cancer Institute (NCI) 35
Testing effectiveness (Phase 2)Study completedNCT01032057
What this trial is testing

Gemcitabine, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer That Cannot Be Removed by Surgery

Who this might be right for
Pancreatic Cancer
Lisette Nixon 114
Testing effectiveness (Phase 2)UnknownNCT01821729
What this trial is testing

Proton w/FOLFIRINOX-Losartan for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 50
Testing effectiveness (Phase 2)Study completedNCT00004895
What this trial is testing

Octreotide as Palliative Therapy for Cancer-Related Bowel Obstruction That Cannot Be Removed by Surgery

Who this might be right for
Colorectal CancerConstipation, Impaction, and Bowel ObstructionExtrahepatic Bile Duct Cancer+7 more
Northwestern University
Testing effectiveness (Phase 2)UnknownNCT01591733
What this trial is testing

FOLFIRINOX + RT for Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Massachusetts General Hospital 48
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07108504
What this trial is testing

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy Effect
Shanghai Zhongshan Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT03908333
What this trial is testing

High Dose Ascorbic Acid and Nanoparticle Paclitaxel Protein Bound and Cisplatin and Gemcitabine (AA NABPLAGEM) in Patients Who Have Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic CancerPancreatic CancerPancreas Cancer+3 more
Medical College of Wisconsin
Testing effectiveness (Phase 2)Study completedNCT01560949
What this trial is testing

Preoperative Folfirinox, Radiation Therapy for Resectable Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 34
Testing effectiveness (Phase 2)Study completedNCT01781728
What this trial is testing

Palliative Stereotactic Radiation for Pancreatic or Periampullary Adenocarcinoma

Who this might be right for
Pancreatic CancerPeriampullary Adenocarcinoma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 48
Testing effectiveness (Phase 2)Study completedNCT00040833
What this trial is testing

Acupuncture and Acupressure in Treating Patients With Moderate or Severe Pain Related to Stage III or Stage IV Pancreatic Cancer

Who this might be right for
PainPancreatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Ended earlyNCT01583686
What this trial is testing

CAR T Cell Receptor Immunotherapy Targeting Mesothelin for Patients With Metastatic Cancer

Who this might be right for
Cervical CancerPancreatic CancerOvarian Cancer+2 more
National Cancer Institute (NCI) 15
Testing effectiveness (Phase 2)Ended earlyNCT01784861
What this trial is testing

VEGFR/PDGFR Dual Kinase Inhibitor X-82 and Everolimus for Treating Patients With Pancreatic Neuroendocrine Tumors

Who this might be right for
AdenocarcinomaPancreatic Neoplasms
Washington University School of Medicine 23
Testing effectiveness (Phase 2)Looking for participantsNCT06051851
What this trial is testing

Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 177
Testing effectiveness (Phase 2)Looking for participantsNCT06404840
What this trial is testing

Evaluating Nimotuzumab in Combination With AG Regimen for Pancreatic Cancer With Liver Metastases : A Prospective, Single-Arm, Phase II Study

Who this might be right for
Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Study completedNCT01488552
What this trial is testing

Gemcitabine+Nab-paclitaxel and FOLFIRINOX and Molecular Profiling for Patients With Advanced Pancreatic Cancer

Who this might be right for
Stage IV Pancreatic Cancer
Pancreatic Cancer Research Team 60
Load More Results